Literature DB >> 35689095

[Radiation therapy of malignant salivary gland tumors].

Katharina Weusthof1,2,3, Jürgen Debus4,5,6,7,8, Sebastian Adeberg4,5,6.   

Abstract

Due to their rarity, histologic heterogeneity, and localization, treatment of malignant salivary gland tumors requires an interdisciplinary approach. First-line treatment includes complete tumor resection. Postoperative radiation therapy is advised in patients with risk factors, i.e., incomplete tumor resection, high-grade tumors, or perineural invasion. Definitive radiation therapy is only advised for inoperable tumors because of significantly lower local control and survival rates when compared to combined surgery and radiation therapy. In radiation oncology, modern techniques such as intensity-modulated radiation therapy (IMRT) or particle therapy with heavy ions (i.e., C12) have led to improved outcomes in the treatment of head and neck tumors, especially of adenoid cystic carcinomas. Given the biological and physical benefits of particles, particle therapy, particularly carbon ion radiation, is a promising therapeutic approach for salivary gland tumors that will be further investigated in prospective clinical studies.
© 2022. The Author(s), under exclusive licence to Springer Medizin Verlag GmbH, ein Teil von Springer Nature.

Entities:  

Keywords:  Cranial nerves; Proton therapy; Radiotherapy; Salivary gland neoplasms; Skull base

Year:  2022        PMID: 35689095     DOI: 10.1007/s00106-022-01188-4

Source DB:  PubMed          Journal:  HNO        ISSN: 0017-6192            Impact factor:   1.284


  3 in total

1.  [Long-term results of postoperative and primary radiotherapy of carcinoma of the salivary glands: importance of dosage and target volume].

Authors:  C Glanzmann
Journal:  Strahlenther Onkol       Date:  1990-03       Impact factor: 3.621

2.  High-grade salivary gland cancer: is surgery followed by radiotherapy an adequate treatment to reach tumor control? Results from a tertiary referral centre focussing on incidence and management of distant metastases.

Authors:  Viola Freitag; Sebastian Lettmaier; Sabine Semrau; Markus Hecht; Konstantinos Mantsopoulos; Sarina K Müller; Maximillian Traxdorf; Heinrich Iro; Abbas Agaimy; Rainer Fietkau; Marlen Haderlein
Journal:  Eur Arch Otorhinolaryngol       Date:  2021-08-26       Impact factor: 3.236

Review 3.  Salivary Gland Carcinoma: Novel Targets to Overcome Treatment Resistance in Advanced Disease.

Authors:  Larissa Di Villeneuve; Ive Lima Souza; Fernanda Davila Sampaio Tolentino; Renata Ferrarotto; Gustavo Schvartsman
Journal:  Front Oncol       Date:  2020-10-22       Impact factor: 6.244

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.